RBI Bonus Zert 1FC 26.03.2025/ AT0000A37M20 /
| 2024-05-10 9:15:02 AM | Chg.0.00 | Bid5:29:55 PM | Ask5:29:55 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 6.27EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
FACC AG INH.AKT. | - EUR | 2025-03-26 | Call |
GlobeNewswire
05-07
Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...
GlobeNewswire
05-07
Rugby Provides Exploration Update on its Gold-Silver Projects in Santa Cruz Province, Argentina
GlobeNewswire
05-02
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...
GlobeNewswire
04-30
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire
04-08
Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire
04-07
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire
04-01
Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire
03-27
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire
03-25
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire
03-25
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire
03-13
Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire
03-12
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire
02-27
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire
02-20
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...
GlobeNewswire
02-07
Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...
GlobeNewswire
01-29
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...
GlobeNewswire
01-23
The International Myeloma Foundation Mourns the Passing of IMF Board Member Dr. Edith Mitchell
GlobeNewswire
2023-12-27
Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammato...
GlobeNewswire
2023-12-20
Renexxion Ireland has Completed a Successful Pre-IND Consultation with the United States FDA for Dev...
